Evidence map›Paper›PMID 39290901›Full record

ArticlePostepy dermatologii i alergologii2024

Study of gut microbiome alterations in plaque psoriasis patients compared to healthy individuals.

Karina Polak, Tomasz Muszyński, Aleksandra Frątczak, Fanni Meznerics, András Bánvölgyi, Norbert Kiss, Bartosz Miziołek, Beata Bergler-Czop

Abstract read
In one paragraph

Article in Postepy dermatologii i alergologii, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Karina PolakDepartment of Dermatology, Medical University of Silesia, Katowice, Poland.
Tomasz MuszyńskiBrothers Hospitallers of Saint John of God Hospital, Krakow, Poland.
Aleksandra FrątczakDepartment of Dermatology, Medical University of Silesia, Katowice, Poland.
Fanni MeznericsDepartment of Dermatology, Venereology and Dermatooncology, Semmelweis University, Budapest, Hungary.
András BánvölgyiDepartment of Dermatology, Venereology and Dermatooncology, Semmelweis University, Budapest, Hungary.
Norbert KissDepartment of Dermatology, Venereology and Dermatooncology, Semmelweis University, Budapest, Hungary.
Bartosz MiziołekDepartment of Dermatology, Medical University of Silesia, Katowice, Poland.
Beata Bergler-CzopDepartment of Dermatology, Medical University of Silesia, Katowice, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Many studies have shown significant alterations in the gut microbiome of patients with psoriasis compared to healthy controls. Aim: The primary objective of the current research was to explore the impact of gut microbiome composition on the progression and severity of plaque psoriasis. Material and methods: A total of 20 patients with moderate-to-severe psoriasis and 20 healthy individuals were recruited and provided a stool sample to assess the gut microbiome. After the samples were prepared according to the NGS library preparation workflow, they were sequenced using the Illumina platform and the report was generated that underwent statistical analysis. Results: The microbiome profiles of psoriasis patients exhibited significant differences compared to healthy controls as evidenced by the statistical analysis of various bacterial genera, with the median abundance significantly lower in psoriasis patients compared to healthy controls ( Conclusions: Overall, the above findings underscore the importance of the gut microbiome in psoriasis and suggest that modulation of specific bacterial genera, especially that with significant differences, could be a potential strategy for therapeutic intervention. Targeting these depleted genera through microbiome-based interventions, such as probiotic supplementation or faecal microbiota transplantation, could potentially help to restore gut homeostasis and alleviate the inflammatory burden in psoriasis.

Indexed as

dysbiosisgut microbiomepsoriasis

Identifiers

PMID39290901
PMCPMC11404103

What Socratic holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.